Login / Signup

Optimal molecular binding data and pharmacokinetic profiles of novel potential triple-action inhibitors of chymase, spleen tyrosine kinase, and prostaglandin D2 receptor in the treatment of asthma.

Precious Ayorinde AkinnusiSamuel Olawale OlubodeAyomide Oluwadarasimi AdebesinAdebowale Abiodun AladeVictor Chinedu NwokeSidiqat Adamson Shodehinde
Published in: Journal, genetic engineering & biotechnology (2023)
These findings suggest that these compounds could be explored as triple-action inhibitors of the protein targets. They are, therefore, recommended for further analysis.
Keyphrases